In a decisive Independence Day victory for American energy security, President Trump signed the One Big Beautiful Bill into law […]
As President Trump leads the charge to modernize America’s supply chains and unleash innovation across the economy, one entrenched interest […]
Crime these days is not just retail smash-and-grabs. It increasingly features a highly organized effort: cargo theft. And it’s costing […]
For the thousands of small businesses, families, and workers in underserved and rural communities across America, opportunity zones represent more […]
The conversation around medical marijuana rescheduling has regained momentum in recent months, drawing notable support from conservatives. Currently classified as […]
The lack of regulation surrounding third-party litigation funding (TPLF) creates a significant legal loophole that could allow hedge funds, foreign […]
CASE Thanks Senator Tillis for Taking Bold Stand Against Foreign-Funded Lawsuits in Trump’s Big Beautiful Bill Senator Thom Tillis identified […]
Buying a home is among the most consequential transactions most Americans will ever face. It is also among the most […]
As discussions over the Reconciliation Bill continue in the Senate, Americans should be deeply concerned by renewed proposals to tax […]
ALEXANDRIA, Va., June 18, 2025 — Today, Consumer Action for a Strong Economy (CASE) launched Hospital Facts, a new consumer watchdog […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/